Shane Barton sold $1.6M of BIOA stock

Shane Barton, Principal Accounting Officer of BioAge Labs, Inc. (BIOA), sold 62,566 shares of BIOA stock worth $1.6M, per an SEC Form 4 filed Jul 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 29, 2026, 2 days before it was made public.

BIOA has moved -77.4% since the trade date, from $24.95 to $5.65 (Nov 12, 2026 close).